デフォルト表紙
市場調査レポート
商品コード
1258158

移植診断の世界市場規模調査&予測、技術別(分子アッセイ、非分子アッセイ)、製品別(試薬・消耗品、機器、ソフトウェア、サービス)、地域分析、2022-2029年

Global Transplant Diagnostics Market Size study & Forecast, by Technology (Molecular Assay, Non-molecular Assay), by Product (Reagents & Consumables, Instruments, Software and Services) and Regional Analysis, 2022-2029

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
移植診断の世界市場規模調査&予測、技術別(分子アッセイ、非分子アッセイ)、製品別(試薬・消耗品、機器、ソフトウェア、サービス)、地域分析、2022-2029年
出版日: 2023年04月10日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の移植診断市場は、2021年に7億2,130万米ドルと評価され、予測期間2022-2029年には7.6%以上の健全な成長率で成長すると予測されています。

移植診断とは、移植の前後に臓器レシピエントとドナーが適合しているかどうかを判断するために実施される検査です。市場の主な促進要因は、移植分野における技術進歩の増加や移植手術件数の増加です。さらに、市場プレイヤーの戦略的な取り組みが、予測期間2022年から2029年にかけて、市場プレイヤーに有利な成長機会を生み出しています。

Bizwit Research &Consulting LLPの調査によると、肝臓、腎臓、心臓、肺の移植に対する強いニーズがあるとのことです。臓器不全は、アルコール使用、薬物中毒、運動不足が原因で起こることがほとんどです。臓器調達・移植ネットワークによると、2021年に米国で実施された臓器移植は41,354件で、前年比5.9%増、年間合計では初めて4万件を超えました。また、臓器移植は患者の生存率とQOLを高め、公衆衛生に大きなプラスの効果をもたらし、臓器不全による社会経済的負担を軽減します。欧州がこの分野のリーダーであるのは、臓器移植に対する欧州連合(EU)の一般的に統一された体系的なアプローチ、確立された国内プログラム、臓器共有を可能にする世界なインフラ、明確に定義された交換政策があるからです。しかし、臓器移植にかかる費用の高さが、予測期間中の市場成長を抑制しています。

移植診断の世界市場調査において考慮された主要地域は、アジア太平洋地域、北米、欧州、中南米、世界のその他の地域です。収益シェアでは、2021年に北米が市場空間を支配しています。主な影響としては、最先端の方法と診断技術の普及、ヘルスケアコストの上昇、有能な人材の入手が挙げられます。高度に確立されたヘルスケアインフラや有能な専門家の確保などの要因から、米国が最大の市場シェアを占めています。また、幹細胞治療や軟部組織移植の普及が、地域の市場拡大を促進しています。また、アジア太平洋地域は、革新的な診断技術の導入が進み、臓器移植の件数が増加していることから、予測期間2022年から2029年にかけて最も速いCAGRで成長しています。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することにあります。本レポートは、調査対象国の産業の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、競合情勢や主要企業の技術提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界・セグメント別市場推定・予測、2019年~2029年
    • 移植診断市場、地域別、2019-2029年
    • 移植診断市場、技術別、2019-2029年
    • 移植診断市場、製品別、2019-2029年
  • 主な動向
  • 調査手法
  • 調査の前提条件

第2章 移植診断の世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 本調査の対象となった年
  • 通貨換算レート

第3章 移植診断の世界市場力学

  • 移植診断市場のインパクト分析(2019-2029年)
    • 市場促進要因
      • 移植分野の技術的進歩の増加
      • 移植手術の件数の増加
    • 市場の課題
      • 臓器移植の高コスト
    • 市場機会
      • 市場主要プレイヤーの戦略的取り組み

第4章 移植診断の世界市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ(2019-2029年)
  • PEST分析
    • 政治的
    • 経済的
    • ソーシャル
    • テクニカル
  • 主な投資機会
  • 主要成功戦略
  • 業界関係者見通し
  • アナリストの提言と結論

第5章 リスク評価:COVID-19の影響

  • COVID-19が業界に与える全体的な影響についての評価
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 移植診断の世界市場:技術別

  • マーケットスナップショット
  • 移植診断の世界市場:技術別、実績 - ポテンシャル分析
  • 移植診断の世界市場技術別推定・予測2019-2029
  • 移植診断市場、サブセグメント別分析
    • 分子アッセイ
    • 非分子アッセイ

第7章 移植診断の世界市場:製品別

  • マーケットスナップショット
  • 移植診断の世界市場:製品別、実績 - ポテンシャル分析
  • 移植診断の世界市場製品別推定・予測2019-2029
  • 移植診断市場、サブセグメント別分析
    • 試薬・消耗品
    • 機器
    • ソフトウェアおよびサービス

第8章 移植診断の世界市場:地域別分析

  • 移植診断市場、地域別市場スナップショット
  • 北米
    • 米国
      • 技術別の推定・予測、2019年~2029年
      • 製品別の推定・予測、2019年~2029年
    • カナダ
  • 欧州移植診断市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の移植診断市場のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの移植診断市場スナップショット
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ地域
  • 世界のその他の地域

第9章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Thermo Fisher Scientific, Inc.
      • 主要な情報
      • 概要
      • 財務(データの入手が可能な場合のみ)
      • 製品概要
      • 最近の動向
    • Illumina, Inc.
    • F. Hoffmann La-Roche AG.
    • Abbott Laboratories, Inc.
    • Qiagen N.V.
    • Immucor Transplant Diagnostics, Inc.
    • Bio-rad Laboratories, Inc.
    • Affymetrix, Inc.
    • Omixon Ltd.
    • Hologic, Inc.
    • Merck KGaA

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Transplant Diagnostics Market, report scope
  • TABLE 2. Global Transplant Diagnostics Market estimates & forecasts by Region 2019-2029 (USD Million)
  • TABLE 3. Global Transplant Diagnostics Market estimates & forecasts by Technology 2019-2029 (USD Million)
  • TABLE 4. Global Transplant Diagnostics Market estimates & forecasts by Product 2019-2029 (USD Million)
  • TABLE 5. Global Transplant Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 6. Global Transplant Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 7. Global Transplant Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 8. Global Transplant Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 9. Global Transplant Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 10. Global Transplant Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 11. Global Transplant Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 12. Global Transplant Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 13. Global Transplant Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 14. Global Transplant Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 15. U.S. Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 16. U.S. Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 17. U.S. Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 18. Canada Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 19. Canada Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 20. Canada Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 21. UK Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 22. UK Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 23. UK Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 24. Germany Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 25. Germany Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 26. Germany Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 27. France Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 28. France Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 29. France Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 30. Italy Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 31. Italy Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 32. Italy Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 33. Spain Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 34. Spain Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 35. Spain Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 36. RoE Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 37. RoE Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 38. RoE Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 39. China Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 40. China Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 41. China Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 42. India Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 43. India Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 44. India Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 45. Japan Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 46. Japan Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 47. Japan Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 48. South Korea Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 49. South Korea Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 50. South Korea Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 51. Australia Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 52. Australia Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 53. Australia Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 54. RoAPAC Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 55. RoAPAC Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 56. RoAPAC Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 57. Brazil Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 58. Brazil Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 59. Brazil Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 60. Mexico Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 61. Mexico Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 62. Mexico Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 63. RoLA Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 64. RoLA Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 65. RoLA Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 66. Row Transplant Diagnostics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 67. Row Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 68. Row Transplant Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 69. List of secondary sources, used in the study of global Transplant Diagnostics Market
  • TABLE 70. List of primary sources, used in the study of global Transplant Diagnostics Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Transplant Diagnostics Market, research methodology
  • FIG 2. Global Transplant Diagnostics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Transplant Diagnostics Market, key trends 2021
  • FIG 5. Global Transplant Diagnostics Market, growth prospects 2022-2029
  • FIG 6. Global Transplant Diagnostics Market, porters 5 force model
  • FIG 7. Global Transplant Diagnostics Market, pest analysis
  • FIG 8. Global Transplant Diagnostics Market, value chain analysis
  • FIG 9. Global Transplant Diagnostics Market by segment, 2019 & 2029 (USD Million)
  • FIG 10. Global Transplant Diagnostics Market by segment, 2019 & 2029 (USD Million)
  • FIG 11. Global Transplant Diagnostics Market by segment, 2019 & 2029 (USD Million)
  • FIG 12. Global Transplant Diagnostics Market by segment, 2019 & 2029 (USD Million)
  • FIG 13. Global Transplant Diagnostics Market by segment, 2019 & 2029 (USD Million)
  • FIG 14. Global Transplant Diagnostics Market, regional snapshot 2019 & 2029
  • FIG 15. North America Transplant Diagnostics Market 2019 & 2029 (USD Million)
  • FIG 16. Europe Transplant Diagnostics Market 2019 & 2029 (USD Million)
  • FIG 17. Asia pacific Transplant Diagnostics Market 2019 & 2029 (USD Million)
  • FIG 18. Latin America Transplant Diagnostics Market 2019 & 2029 (USD Million)
  • FIG 19. Global Transplant Diagnostics Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Transplant Diagnostics Market is valued approximately USD 721.30 million in 2021 and is anticipated to grow with a healthy growth rate of more than 7.6% over the forecast period 2022-2029. Transplant diagnostics are tests carried out to determine whether the organ recipient and donor are compatible before or after transplant. The major driving factor for the market are increase in the technological advancements in the field of transplants and rising number of transplant procedures. Moreover, strategic initiatives by market players is creating lucrative growth opportunity for the market players over the forecast period 2022-2029.

According to the research conducted at Bizwit Research & Consulting LLP, there is a strong need for liver, kidney, heart, and lung transplants. Organ failure is most commonly caused by alcohol usage, drug addiction, and inactivity. According to the Organ Procurement and Transplantation Network, 41,354 organ transplants were carried out in the United States in 2021, a 5.9 percent increase over the previous year and the first time the yearly total went above 40,000. Organ transplantation also increases patient survival and quality of life, has a significant positive effect on public health, and reduces the socioeconomic burden of organ failure. Europe is a leader in this field because of the European Union's (EU) generally uniform and systematic approach to organ transplantation, well-established national programmes, global infrastructure to allow organ sharing, and clearly defined exchange policies. However, high cost of organ transplantation is restraining the market growth over the forecast period.

The key regions considered for the Global Transplant Diagnostics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In terms of revenue share, North America is dominating the market space in 2021. Major influences include the widespread use of cutting-edge methods and diagnostic technologies, rising healthcare costs, and the accessibility of qualified personnel. Due to factors including a highly established healthcare infrastructure and the availability of qualified specialists, the U.S. has the biggest market share. Additionally, the widespread use of stem cell therapies, and soft tissue transplants is promoting regional market expansion. Along with this, Asia Pacific is growing with the fastest CAGR over the forecast period 2022-2029 owing to rising adoption of innovative diagnostic technology, and rising number of organ transplant in the region excelling the growth of the market.

Major market players included in this report are:

  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • F. Hoffmann La-Roche AG.
  • Abbott Laboratories, Inc.
  • Qiagen N.V.
  • Immucor Transplant Diagnostics, Inc.
  • Bio-rad Laboratories, Inc.
  • Affymetrix, Inc.
  • Omixon Ltd.
  • Hologic, Inc.
  • Merck KGaA

Recent Developments in the Market:

  • In October 2022, the US-based biotechnology company Plexision, has started conducting business abroad with the opening of a reference laboratory in Hyderabad, India. This facility will provide transplant patients with a wide variety of diagnostics. These tests include drug level monitoring, genetic testing, pharmacogenomics, and the company's unique tailored transplant diagnostic assays to anticipate viral infections and rejection.
  • In March 2022, Immucor, Inc., a leader in transfusion and transplantation diagnostics, recently announced the addition of two new products to its portfolio of transplant diagnostics, illustrating their dedication to new developments in the histocompatibility sector.

Global Transplant Diagnostics Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Technology, Product, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Technology offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Technology:

  • Molecular Assay
  • Non-molecular Assay

By Product:

  • Reagents & Consumables
  • Instruments
  • Software and Services

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
    • 1.2.1. Transplant Diagnostics Market, by Region, 2019-2029 (USD Million)
    • 1.2.2. Transplant Diagnostics Market, by Technology, 2019-2029 (USD Million)
    • 1.2.3. Transplant Diagnostics Market, by Product, 2019-2029 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Transplant Diagnostics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Transplant Diagnostics Market Dynamics

  • 3.1. Transplant Diagnostics Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increase in the technological advancements in the field of transplants
      • 3.1.1.2. Rising number of transplant procedures
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of organ transplantation
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Strategic initiatives by the key market players

Chapter 4. Global Transplant Diagnostics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Transplant Diagnostics Market, by Technology

  • 6.1. Market Snapshot
  • 6.2. Global Transplant Diagnostics Market by Technology, Performance - Potential Analysis
  • 6.3. Global Transplant Diagnostics Market Estimates & Forecasts by Technology 2019-2029 (USD Million)
  • 6.4. Transplant Diagnostics Market, Sub Segment Analysis
    • 6.4.1. Molecular Assay
    • 6.4.2. Non-molecular Assay

Chapter 7. Global Transplant Diagnostics Market, by Product

  • 7.1. Market Snapshot
  • 7.2. Global Transplant Diagnostics Market by Product, Performance - Potential Analysis
  • 7.3. Global Transplant Diagnostics Market Estimates & Forecasts by Product 2019-2029 (USD Million)
  • 7.4. Transplant Diagnostics Market, Sub Segment Analysis
    • 7.4.1. Reagents & Consumables
    • 7.4.2. Instruments
    • 7.4.3. Software and Services

Chapter 8. Global Transplant Diagnostics Market, Regional Analysis

  • 8.1. Transplant Diagnostics Market, Regional Market Snapshot
  • 8.2. North America Transplant Diagnostics Market
    • 8.2.1. U.S. Transplant Diagnostics Market
      • 8.2.1.1. Technology breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Product breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Transplant Diagnostics Market
  • 8.3. Europe Transplant Diagnostics Market Snapshot
    • 8.3.1. U.K. Transplant Diagnostics Market
    • 8.3.2. Germany Transplant Diagnostics Market
    • 8.3.3. France Transplant Diagnostics Market
    • 8.3.4. Spain Transplant Diagnostics Market
    • 8.3.5. Italy Transplant Diagnostics Market
    • 8.3.6. Rest of Europe Transplant Diagnostics Market
  • 8.4. Asia-Pacific Transplant Diagnostics Market Snapshot
    • 8.4.1. China Transplant Diagnostics Market
    • 8.4.2. India Transplant Diagnostics Market
    • 8.4.3. Japan Transplant Diagnostics Market
    • 8.4.4. Australia Transplant Diagnostics Market
    • 8.4.5. South Korea Transplant Diagnostics Market
    • 8.4.6. Rest of Asia Pacific Transplant Diagnostics Market
  • 8.5. Latin America Transplant Diagnostics Market Snapshot
    • 8.5.1. Brazil Transplant Diagnostics Market
    • 8.5.2. Mexico Transplant Diagnostics Market
    • 8.5.3. Rest of Latin America Transplant Diagnostics Market
  • 8.6. Rest of The World Transplant Diagnostics Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Thermo Fisher Scientific, Inc.
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Illumina, Inc.
    • 9.2.3. F. Hoffmann La-Roche AG.
    • 9.2.4. Abbott Laboratories, Inc.
    • 9.2.5. Qiagen N.V.
    • 9.2.6. Immucor Transplant Diagnostics, Inc.
    • 9.2.7. Bio-rad Laboratories, Inc.
    • 9.2.8. Affymetrix, Inc.
    • 9.2.9. Omixon Ltd.
    • 9.2.10. Hologic, Inc.
    • 9.2.11. Merck KGaA

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption